Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL840 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL6753447 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL3242781 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL2025829 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL465441 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL1578131 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL782452 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL40571 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL126310 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL9398542 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 432 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120057954-A | Method for preparing schoenite-containing mixed salt from sulfate type salt lake polyhalite | 中国科学院青海盐湖研究所 | 2025-05-30 | — | — | CN | claimed |
| WO-2025101054-A1 | BRINE VALORISATION METHOD FOR A BRINE ORIGINATING FROM SEAWATER DESALINATION | Universite Mohammed VI Polytechnique (MA) | 2025-05-15 | — | — | WO | claimed |
| CN-119551695-A | Method for preparing high-purity magnesium oxide from nickel-iron slag by recycling magnesium | 广西大学 | 2025-03-04 | — | — | CN | claimed |
| CN-116081659-B | Asbestos tailing refined magnesium sulfate solution and method and application thereof | 西南科技大学 | 2024-11-19 | — | — | CN | claimed |
| CN-118561303-B | Low-cost high-purity high-densification spherical magnesia powder and preparation method thereof | 山东工业陶瓷研究设计院有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-115895946-B | Nitrite accumulation type denitrifying achromobacter and application thereof | 曲阜师范大学 | 2024-10-15 | — | — | CN | claimed |
| CN-118561303-A | Low-cost high-purity high-densification spherical magnesia powder and preparation method thereof | 山东工业陶瓷研究设计院有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118108470-A | Composite phase-change material heat-insulating wallboard and sunlight greenhouse | 大庆市智新惠丰农业科技有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-116948388-A | High-air-permeability polyurethane sponge mattress and preparation method thereof | 玺堡(福建)家居有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116808818-A | Composite biomass filler and method for removing methyl mercaptan by using biological trickling filter | 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) | 2023-09-29 | — | — | CN | claimed |
| US-8951305-B2 | Method of producing naturally purified salt products | CARGILL, INCORPORATED (US) | 2015-02-10 | — | — | US | claimed |
| WO-2012122168-A2 | METHOD AND APPARATUS FOR ACCUMULATING, STORING, AND RELEASING THERMAL ENERGY AND HUMIDITY | WEXLER RONALD M (US) | 2012-09-13 | — | — | WO | claimed |
| US-20120066868-A1 | METHOD OF PRODUCING NATURALLY PURIFIED SALT PRODUCTS | CARGILL, INCORPORATED | 2012-03-22 | — | — | US | claimed |
| US-20110262563-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | NOVENTIS, INC. (US) | 2011-10-27 | — | — | US | claimed |
| US-20110154737-A1 | METHOD AND APPARATUS FOR ACCUMULATING, STORING, AND RELEASING THERMAL ENERGY AND HUMIDITY | WEXLER RONALD M | 2011-06-30 | — | — | US | claimed |
| WO-2010138583-A1 | METHOD OF PRODUCING NATURALLY PURIFIED SALT PRODUCTS | CARGILL, INCORPORATED (US) | 2010-12-02 | — | — | WO | claimed |
| US-20070224108-A1 | Method for Reducing Reactivity of Calcium Hypochlorite | BARCLAYS BANK PLC | 2007-09-27 | — | — | US | claimed |
| EP-0652180-B1 | Method for recovering magnesium sulfate products from mixtures of epsomite and halite | EXPORTADORA DE SAL SACV (MX) | 1997-05-21 | — | — | EP | claimed |
| EP-0652180-A1 | Method for recovering magnesium sulfate products from mixtures of epsomite and halite | EXPORTADORA DE SAL S.A. DE C.V. (MX) | 1995-05-10 | — | — | EP | claimed |
| US-5281242-A | Method for recovering magnesium sulfate products from mixtures of epsomite and halite | EXPORTADORA DE SAL, S.A DE C.V. (MX) | 1994-01-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110262563-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | TNNI3, TNNC1, TNNT2 | MEN1 4349/4885ALDH1A1 1610/4885TSHR 4296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.